1. Home
  2. PDFS vs COLL Comparison

PDFS vs COLL Comparison

Compare PDFS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PDF Solutions Inc.

PDFS

PDF Solutions Inc.

HOLD

Current Price

$37.03

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Collegium Pharmaceutical Inc.

COLL

Collegium Pharmaceutical Inc.

HOLD

Current Price

$33.53

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PDFS
COLL
Founded
1992
2002
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2000
2015

Fundamental Metrics

Financial Performance
Metric
PDFS
COLL
Price
$37.03
$33.53
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$33.67
$51.40
AVG Volume (30 Days)
290.3K
496.0K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
1.73
Revenue
N/A
$780,567,000.00
Revenue This Year
$22.13
$8.01
Revenue Next Year
$18.92
N/A
P/E Ratio
N/A
$18.94
Revenue Growth
N/A
23.62
52 Week Low
$16.63
$23.23
52 Week High
$36.99
$50.79

Technical Indicators

Market Signals
Indicator
PDFS
COLL
Relative Strength Index (RSI) 63.10 37.32
Support Level $30.71 $31.01
Resistance Level N/A $36.20
Average True Range (ATR) 1.77 1.22
MACD 0.24 0.31
Stochastic Oscillator 89.22 35.08

Price Performance

Historical Comparison
PDFS
COLL

About PDFS PDF Solutions Inc.

PDF Solutions Inc provides products and services designed to empower organizations across the semiconductor and electronics ecosystem to connect, collect, manage, and analyze data about design, equipment, manufacturing, and test to improve the yield and quality of their products and operational efficiency. The Company's products, services, and solutions include proprietary software, physical intellectual property (IP) for integrated circuit (IC) designs, electrical measurement hardware tools, methodologies, and professional services.

About COLL Collegium Pharmaceutical Inc.

Collegium Pharmaceutical Inc is a diversified biopharmaceutical company committed to improving the lives of people living with serious medical conditions. The company has developed, licensed, and acquired a portfolio of meaningfully differentiated products for the treatment of attention deficit hyperactivity disorder (ADHD) and moderate to severe pain. It commercializes its products in the United States, including Jornay PM, Belbuca, Xtampza ER, Nucynta ER, Nucynta IR (collectively, the Nucynta Products), and Symproic. The company's product portfolio includes Jornay PM, Belbuca, Xtampza ER, Nucynta IR, Nucynta ER, and Symproic.

Share on Social Networks: